{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:50:36Z","timestamp":1649127036530},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.regg.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T20:13:58Z","timestamp":1555186438000},"page":"296-299","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Toxicidad grave por metotrexato en el anciano: nuestra experiencia en los \u00faltimos 7 a\u00f1os"],"prefix":"10.1016","volume":"54","author":[{"given":"Rita","family":"Nogueiras \u00c1lvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Narc\u00eds","family":"Nan Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Olmos Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Fern\u00e1ndez-Ayala Novo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regg.2019.02.002_bib0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.reuma.2009.10.006","article-title":"Actualizaci\u00f3n del Documento de Consenso de la Sociedad Espa\u00f1ola de Reumatolog\u00eda sobre el uso de terapias biol\u00f3gicas en la artritis reumatoide","volume":"6","author":"Tornero Molina","year":"2010","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.regg.2019.02.002_bib0060","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1200\/JCO.1994.12.8.1667","article-title":"Patient characteristics associated with high risk methotrexate concentrations and toxicity","volume":"12","author":"Relling","year":"1994","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.regg.2019.02.002_bib0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/art.1780390214","article-title":"Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis","volume":"39","author":"Gutierrez-Ure\u00f1a","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.regg.2019.02.002_bib0070","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.autrev.2014.08.027","article-title":"Clinical characteristics and risk factors for low dose methotrexate toxicity: A cohort of 28 patients","volume":"13","author":"Kivity","year":"2014","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.regg.2019.02.002_bib0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cger.2012.01.002","article-title":"Polypharmacy adverse drug reactions, and geriatric syndromes","volume":"28","author":"Shah","year":"2012","journal-title":"Clin Geriatr Med."},{"key":"10.1016\/j.regg.2019.02.002_bib0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hon.2479","article-title":"Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?","volume":"36","author":"Ranchon","year":"2018","journal-title":"Hematol Oncol."},{"key":"10.1016\/j.regg.2019.02.002_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reuma.2014.02.012","article-title":"Recommendations for the use of methotrexate in rheumatoid arthritis: Up and down scaling of the dose and administration routes","volume":"11","author":"Tornero Molina","year":"2015","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.regg.2019.02.002_bib0090","unstructured":"Nota informativa de la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios sobre Metotrexato. Posible confusi\u00f3n en la dosis de Metotrexato administrado por v\u00eda oral. Ref: 2004\/04. [consultado 27 Jul 2004]. Disponible en: https:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2004\/NI_2004-07_metotrexato.htm"},{"key":"10.1016\/j.regg.2019.02.002_bib0095","doi-asserted-by":"crossref","unstructured":"Metotrexato por v\u00eda oral: reacciones adversas graves derivadas de la confusi\u00f3n en la dosis administrada. Referencia: MUH (FV), 11\/2011. Fecha de publicaci\u00f3n: 13 de julio de 2011. [consultado 13 Jul 2011]. Disponible en: https:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2011\/NI-MUH_11-2011.htm","DOI":"10.5211\/iys.10.article3"},{"key":"10.1016\/j.regg.2019.02.002_bib0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.reuma.2014.02.013","article-title":"Aplasia medular grave secundaria a intoxicaci\u00f3n por metotrexato en un paciente con artritis reumatoide de inicio senil","volume":"10","author":"Exp\u00f3sito","year":"2014","journal-title":"Reumatol Clin."}],"container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X19300381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X19300381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T11:04:20Z","timestamp":1567163060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211139X19300381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0211139X19300381"],"URL":"https:\/\/doi.org\/10.1016\/j.regg.2019.02.002","relation":{},"ISSN":["0211-139X"],"issn-type":[{"value":"0211-139X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicidad grave por metotrexato en el anciano: nuestra experiencia en los \u00faltimos 7 a\u00f1os","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regg.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SEGG. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}